Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer.

Oral Oncol

Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India. Electronic address:

Published: November 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.oraloncology.2022.106085	DOI Listing

Publication Analysis

long term

term outcomes

outcomes randomized

randomized controlled

controlled clinical

clinical trial

trial comparing

comparing efficacy

efficacy cabazitaxel

cabazitaxel versus

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!